234 related articles for article (PubMed ID: 20443996)
1. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature.
Bronsard V; Paul C; Prey S; Puzenat E; Gourraud PA; Aractingi S; Aubin F; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Richard-Lallemand MA; Ortonne JP
J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():17-22. PubMed ID: 20443996
[TBL] [Abstract][Full Text] [Related]
2. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.
De Korte J; Mombers FM; Sprangers MA; Bos JD
Arch Dermatol; 2002 Sep; 138(9):1221-7; discussion 1227. PubMed ID: 12224984
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
[TBL] [Abstract][Full Text] [Related]
4. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials.
McKenna SP; Cook SA; Whalley D; Doward LC; Richards HL; Griffiths CE; Van Assche D
Br J Dermatol; 2003 Aug; 149(2):323-31. PubMed ID: 12932239
[TBL] [Abstract][Full Text] [Related]
5. Impact of psoriasis on quality of life in Iran.
Aghaei S; Moradi A; Ardekani GS
Indian J Dermatol Venereol Leprol; 2009; 75(2):220. PubMed ID: 19293529
[TBL] [Abstract][Full Text] [Related]
6. [Creation and cross-cultural adaptation of the Ukrainian versions of SKINDEX-29, SKINDEX-16 questionnaires, Psoriasis Disability Index and further validation of the Ukrainian version of the Dermatology Life Quality Index].
Chernyshov PV
Lik Sprava; 2009; (1-2):95-8. PubMed ID: 19953996
[TBL] [Abstract][Full Text] [Related]
7. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients.
Nijsten T; Meads DM; de Korte J; Sampogna F; Gelfand JM; Ongenae K; Evers AW; Augustin M
J Invest Dermatol; 2007 Oct; 127(10):2315-22. PubMed ID: 17495953
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
[TBL] [Abstract][Full Text] [Related]
9. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
[TBL] [Abstract][Full Text] [Related]
10. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
[TBL] [Abstract][Full Text] [Related]
11. Validation and application of the Dermatology Life Quality Index score, a modification of the DLQI score, in psoriasis patients.
Zou Q; Luo Y; Hao D; Li M; Jihui C
J Health Popul Nutr; 2024 Jun; 43(1):92. PubMed ID: 38909238
[TBL] [Abstract][Full Text] [Related]
12. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results.
Augustin M; Wenninger K; Amon U; Schroth MJ; Küster W; Chren M; Kupfer J; Gieler U
Dermatology; 2004; 209(1):14-20. PubMed ID: 15237262
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in adult atopic dermatitis and psoriatic patients matched by disease severity.
Chernyshov PV
G Ital Dermatol Venereol; 2016 Feb; 151(1):37-43. PubMed ID: 24927171
[TBL] [Abstract][Full Text] [Related]
14. Quality of life assessments in dermatology.
Finlay AY
Semin Cutan Med Surg; 1998 Dec; 17(4):291-6. PubMed ID: 9859917
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis.
Finlay AY; Salek MS; Haney J;
Dermatology; 2003; 206(4):307-15. PubMed ID: 12771471
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of quality of life in patients with psoriasis from Lithuania and Ukraine].
Chernyshov PV; Bylaĭte M
Lik Sprava; 2010; (7-8):107-11. PubMed ID: 21714295
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.
Ali FM; Cueva AC; Vyas J; Atwan AA; Salek MS; Finlay AY; Piguet V
Br J Dermatol; 2017 Mar; 176(3):577-593. PubMed ID: 27273146
[TBL] [Abstract][Full Text] [Related]
18. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
[TBL] [Abstract][Full Text] [Related]
19. Development of the US PSORIQoL: a psoriasis-specific measure of quality of life.
McKenna SP; Lebwohl M; Kahler KN
Int J Dermatol; 2005 Jun; 44(6):462-9. PubMed ID: 15941432
[TBL] [Abstract][Full Text] [Related]
20. "DLQI Seems to be 'Action', and Skindex-29 Seems to be 'Emotion'": Qualitative Study of the Perceptions of Patients with Psoriasis or Eczema on Two Common Dermatology-specific Quality of Life Measures.
Paudyal P; Apfelbacher C; Jones C; Siddiqui S; El-Turki A; DeGiovanni C; Smith H
Acta Derm Venereol; 2020 Apr; 100(8):adv00105. PubMed ID: 32020205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
